巴贾医疗与一家欧洲公司签署了API开发和供应协议,用于临床试验. Bajaj Healthcare signs API development and supply deal with a European firm for clinical trials.

巴贾奇医疗与欧洲实体签署了一项药物活性成分 (API) 开发和供应协议, Bajaj Healthcare has signed a development and supply agreement with a European entity for an Active Pharmaceutical Ingredient (API), initially supplying small quantities for clinical trials. 伙伴关系强调巴哈杰遵守良好制造做法及其制造能力。 The partnership underscores Bajaj's compliance with Good Manufacturing Practices and its manufacturing capabilities. 该 API 将在其位于巴罗达 Savli 的 FDA 批准的工厂生产，等待试验成功。 The API will be produced at its FDA-approved facility in Savli, Vadodara, pending successful trial outcomes. 公告发布后，Bajaj 的股票大幅上涨。 Following the announcement, Bajaj's stock rose significantly.